Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China

About 10 million people in China are infected with hepatitis C virus (HCV), with the seroprevalence of anti-HCV in the general population estimated at 0.6%. Delaying effective treatment of chronic hepatitis C (CHC) is associated with liver disease progression, cirrhosis, hepatocellular carcinoma, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qing, Xuan, Jian-Wei, Tang, Hong, Ye, Xiao-Guang, Xu, Peng, Lee, I-Heng, Hu, Shan-Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547290/
https://www.ncbi.nlm.nih.gov/pubmed/31183003
http://dx.doi.org/10.4254/wjh.v11.i5.421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547290/
https://www.ncbi.nlm.nih.gov/pubmed/31183003
http://dx.doi.org/10.4254/wjh.v11.i5.421

Ejemplares similares